Endothelial dysfunction and reduced BRS (baroreflex sensitivity) may be present in patients with CAD (coronary artery disease). The normal fasting glucose level does not exclude abnormal glucose metabolism in patients with CAD. The aim of present study was to evaluate endothelial function and BRS according to glucose metabolism in patients with normal fasting plasma glucose and stable CAD subjected to PTCA (percutaneous transluminal coronary angioplasty). Forty-six consecutive patients who underwent elective PTCA were studied (37 men; mean age 56 years). Endothelial function was assessed non-invasively using the arterial vasodilator response to salbutamol (albuterol). BRS was measured using a cross-correlation method. The extent of coronary narrowing was estimated by calculation of the Gensini score. All patients underwent a 75 g OGTT (oral glucose tolerance test). IGT (impaired glucose tolerance) or diabetes was present in approx. 60 % of patients. The vasodilator response to salbutamol, as a measure of endothelial dysfunction, was significantly impaired in patients with IGT or diabetes compared with those with normal glucose tolerance (− 0.5 + − 1.6 % compared with − 7.9 + − 2.2; P = 0.01). Glucose metabolism and age were significant predictors of endothelial dysfunction (R 2 = 35.2 %, P = 0.02). BRS did not differ significantly between patients with normal glucose tolerance and those with IGT or diabetes (6.9 + − 1.2 compared with 6.1 + − 0.6 ms/mmHg respectively; P = 0.669). BRS was negatively correlated with age (r = − 0.34, P = 0.021) and the Gensini score (r = − 0.34, P = 0.022). The significant predictors of BRS were Gensini score, age and past myocardial infarction (R 2 = 37.02 %, P = 0.002). Patients with established CAD, normal fasting glucose and IGT or diabetes demonstrated impaired endothelial function which did not correlate with the extent of coronary artery involvement. Conversely, BRS in the study population was not affected by glucose metabolism, but showed an interaction with the extent of coronary narrowing.
A B S T R A C T
Endothelial dysfunction and reduced BRS (baroreflex sensitivity) may be present in patients with CAD (coronary artery disease). The normal fasting glucose level does not exclude abnormal glucose metabolism in patients with CAD. The aim of present study was to evaluate endothelial function and BRS according to glucose metabolism in patients with normal fasting plasma glucose and stable CAD subjected to PTCA (percutaneous transluminal coronary angioplasty). Forty-six consecutive patients who underwent elective PTCA were studied (37 men; mean age 56 years). Endothelial function was assessed non-invasively using the arterial vasodilator response to salbutamol (albuterol). BRS was measured using a cross-correlation method. The extent of coronary narrowing was estimated by calculation of the Gensini score. All patients underwent a 75 g OGTT (oral glucose tolerance test). IGT (impaired glucose tolerance) or diabetes was present in approx. 60 % of patients. The vasodilator response to salbutamol, as a measure of endothelial dysfunction, was significantly impaired in patients with IGT or diabetes compared with those with normal glucose tolerance (− 0.5 + − 1.6 % compared with − 7.9 + − 2.2; P = 0.01). Glucose metabolism and age were significant predictors of endothelial dysfunction (R 2 = 35.2 %, P = 0.02). BRS did not differ significantly between patients with normal glucose tolerance and those with IGT or diabetes (6.9 + − 1.2 compared with 6.1 + − 0.6 ms/mmHg respectively; P = 0.669). BRS was negatively correlated with age (r = − 0.34, P = 0.021) and the Gensini score (r = − 0.34, P = 0.022). The significant predictors of BRS were Gensini score, age and past myocardial infarction (R 2 = 37.02 %, P = 0.002). Patients with established CAD, normal fasting glucose and IGT or diabetes demonstrated impaired endothelial function which did not correlate with the extent of coronary artery involvement. Conversely, BRS in the study population was not affected by glucose metabolism, but showed an interaction with the extent of coronary narrowing.
INTRODUCTION
Impaired endothelial function and reduced BRS (baroreflex sensitivity) are important predictors of cardiovascular morbidity. Endothelial dysfunction and impaired BRS have been observed in patients with CAD (coronary artery disease) [1] [2] [3] . Type II diabetes is a very important risk factor for the development of CAD and is also associated with reduced BRS, as well as impaired endothelial vasodilator response. Overt diabetes is usually discovered after few years of its slow development and progression. It is known that IGT (impaired glucose tolerance) and diabetes are commonly undiagnosed in patients with stable CAD and in survivors of MI (myocardial infarction) [4, 5] . Both of these disturbances of carbohydrate metabolism may be accompanied by normal fasting plasma glucose which obscures correct diagnosis further. There are very few data about endothelial function and autonomic regulation of cardiovascular system in these subjects. Therefore the aim of the present study was to assess systemic endothelial vasodilator function and BRS in patients with proven CAD, normal fasting glucose and no previously known IGT or Type II diabetes. In addition, we attempted to evaluate the association between the extent of coronary artery narrowing, endothelial function and BRS.
Endothelial function and BRS were assessed noninvasively using PWA (pulse wave analysis) [6] [7] [8] and the spontaneous cross-correlation method respectively.
METHODS

Study patients
The study group consisted of 46 consecutive patients (37 men; aged 35-75 years; mean age, 56 years) undergoing elective PTCA (percutaneous transluminal coronary angioplasty) for the treatment of stable CAD. Exclusion criteria for the study were known diabetes, IGT, impaired fasting glycaemia, renal insufficiency, non-sinus rhythm, unstable angina, MI < 3 months and heart failure (New York Heart Association class II-IV).
The Institutional Ethics Committee approved the study protocol, and informed consent was obtained from each participant.
Study protocol
All patients underwent a successful PTCA, defined as a reduction in stenosis to < 50 % of the total vessel diameter. The severity of coronary atherosclerosis was estimated by calculating the Gensini score [9] , which is based on the evaluation of the number of stenotic coronary artery segments, the degree of their lumen stenosis and the localization of stenotic changes. Each Gensini score is expressed as a percentage of the maximal possible score for the individual coronary anatomy in each patient. Scoring was performed by two observers, who were unaware of the results of laboratory data, and averaged.
Patients underwent a 75 g OGTT (oral glucose tolerance test) on days 2 and 3 after PTCA. Plasma glucose levels were obtained from patients after overnight fast (at least 8 h), before (0 h) and 2 h after the glucose load. IGT or diabetes was diagnosed according to the criteria of the American Diabetes Association [10] .
Peripheral and central haemodynamics assessed by PWA
Measurements were carried out in the morning before PTCA. Patients refrained from alcohol and caffeine for at least 24 h. The laboratory technician performing the study collected the date of birth, weight and height of the patients and was unaware of any other clinical data of the study patients. For the measurement of the wave reflection indices and central haemodynamics, we used the Sphygmocor Mx validated system (software version 7.0; AtCor Medical) [11, 12] . An arterial tonometer (CBM 7000; Colin Medical Instruments) connected to the Sphygmocor Mx device was attached to the subject's wrist to trace the radial artery pulse shape. Patients were studied in supine position after 15 min of rest in a quiet room. The average peripheral and derived aortic waveforms were generated after acquisition of ten sequential pulse waveforms. These waveforms were analysed further by the SphygmoCor software. The central augmentation pressure and AIx (augmentation index) were derived from the reconstructed central pressure waveform. AIx was calculated as the difference between the second and the first systolic peaks observed on the central arterial waveform, and were expressed as a percentage of the central pulse pressure. AIx was regarded as an indirect measure of arterial stiffness.
Endothelial function
The PWA technique, as described by Wilkinson et al. [7] , was used to assess endothelial function. Briefly, after obtaining the resting wave form as described above, salbutamol (albuterol; 2 × 200 µg) was given by inhalation with the use of a spacer device. To ensure good reproducibility of results, the subjects were asked to inhale slowly for 50 s and then to hold their breath for 10 s. After a 30 s pause, this procedure was repeated. Recordings of pulse waveforms were made after 5, 10 and 15 min following salbutamol inhalation. The response to salbutamol was defined as the maximum difference in AIx obtained at baseline and after drug administration. The present study was conducted in order to assess the endothelium-dependent vasodilation; therefore the effect on nitroglycerine-induced non-endothelium-dependent vasodilatation was not measured. 
BRS
A Portapres 2 device (FMS; Amsterdam) was used to obtain a non-invasive beat-to-beat BP (blood pressure) recordings at the finger level. A special cuff was applied to the middle phalanx of the third or fourth finger of the right patient hand. This allowed continuous recording of pulse pressure waves. Finger SBP (systolic BP) and the duration of each cardiac cycle, the so called IBI (inter-beat interval), were obtained from the original pulse pressure curve with the use of Beatscope software (FMS). BRS was measured during 5 min resting recordings with the use of a cross-correlation method computing time-domain sequential BRS on spontaneous SBP and IBI variability. This method observes a window of fixed 10 s length of BP and heart rate and computes the running cross-correlation and regression between SBP and IBI for positive time shifts in IBI of 0-5 s to obtain BRS at the shift with the highest cross-correlation, significant at P = 0.01, and with a positive regression slope. The regression slope of IBI on SBP is divided by the correlation coefficient and used as a BRS estimate. The procedure is repeated several times by shifting the window over the whole recording, resulting in a series of BRS values over time. The geometric mean of the series obtained of BRS estimates from each 5 min segment was taken for analysis further. The method used for BRS calculation is known as xBRS (PRVBRS.EXE, written by K. H. W.). 
Statistical analysis
RESULTS
Study population
We enrolled 46 consecutive patients undergoing PTCA for the treatment of stable CAD (nine women and 37 men; age, 55.9 + − 1.4 years; mean + − S.E.M.). The clinical characteristics of patients are shown in Table 1 . All of the subjects had an OGGT before hospital discharge. Of the patients enrolled, 30 (65 %) met the criteria for IGT or diabetes. There were no significant differences between patients with normal glucose tolerance and the remaining subjects with regard to clinical variables, such as age, gender, previous MI, Gensini score, hypertension, BMI (body mass index) or hyperlipidaemia. Concomitant treatment did not differ significantly between those patients with normal OGTT and those with IGT or diabetes.
Haemodynamic variables
A summary of peripheral and central haemodynamics is shown Table 2 . Peripheral and central BP did not differ between the two groups. It was also observed that there was no significant difference in the resting AIx between the studied groups. Data from all the subjects showed that there was a significant positive correlation between AIx and age (r = 0.41, P = 0.004).
Assessment of endothelial function
After administration of salbutamol, AIx decreased in both of the groups studied. However, this response was significantly impaired in patients with IGT or diabetes in comparison with those with a normal OGTT (− 0.5 + − 1.6 % compared with 7.9 + − 2.2 respectively; P = 0.01). It was observed that the time to maximum change did not differ significantly between groups (7.5 + − 0.9 compared with 9.6 + − 0.9 min respectively; P = 0.144). Data from all subjects were used to construct a multiple linear regression model (Table 3) with the change in AIx as the dependent variable and glucose tolerance, age, Gensini score, BMI and previous MI as independent
Figure 1 Correlation between BRS and the severity of coronary atherosclerosis (A) and age of patients (B) with stable CAD
variables. This model explained the 35 % variability in response to salbutamol observed in the present study. Changes in AIx were negatively correlated with impaired glucose metabolism and age.
BRS
BRS did not differ significantly between the patients with normal glucose tolerance and those with IGT or diabetes (6.9 + − 1.2 compared with 6.1 + − 0.6 ms/mmHg respectively; P = 0.669). BRS was negatively correlated with the Gensini score ( Figure 1A ) and age ( Figure 1B) . A multiple regression model was constructed with BRS as the dependent variable and glucose tolerance, age, Gensini score, BMI and previous MI as independent variables (Table 3) . This model explained the 37 % variability in BRS observed in the studied population. Age, Gensini score and previous MI were negatively correlated with BRS, whereas IGT did not contribute significantly to BRS variability.
DISCUSSION
The major finding of the present study is that the vasodilator response to salbutamol, an indirect measure of endothelial function, is the only clinical variable that differs between CAD patients with IGT or diabetes and those with CAD and normal OGTT. Endothelial dysfunction was not correlated with the extent of coronary artery involvement assessed by the Gensini score. We found that BRS was not affected by glucose metabolism in either subgroup but, in contrast, BRS function was associated with the extent of coronary artery stenosis.
Endothelial dysfunction in patients with stable CAD
Coronary atherosclerosis is associated with abnormal endothelial function in both the coronary arteries [13] and extracoronary vascular bed [14] . Thus the impairment of endothelial function is of a systemic nature. It was, therefore, concluded that testing endothelial function in a peripheral artery may be applied as a useful index of 'vascular health'. Indeed, coronary risk factors which affect endothelium-dependent dilation of peripheral arteries in otherwise healthy subjects are associated with endothelial dysfunction in CAD [15] . The gold standard for the assessment of coronary artery endothelial function is the vasomotor response of the epicardial arteries to the intracoronary infusion of acetylcholine [13] . The invasive nature of this procedure seriously limits the potential population of patients who can be subjected to the assessment of endothelial function. This difficulty led to studies that allow the replacement of this technique by a non-invasive approach. FMD (flow-mediated dilation) of the brachial artery is currently widely used for the assessment of endothelium impairment. Recent studies indicate that other non-invasive techniques, such as digital volume plethysmography and measures of arterial stiffness, are also feasible methods of assessing of endothelial function [7, 16] . Using FMD, Neunteufl et al. [17] demonstrated that systemic endothelial dysfunction is related to the extent and severity of CAD. However, as atherosclerosis does not affect the coronary bed uniformly but has a variable local distribution, it is not very likely that testing of endothelial function would enable an observer to predict the degree of atherosclerosis in the coronary vessels. Likewise, in our present study, we were unable to show that endothelial function correlates with the extent of coronary narrowing, as estimated by calculating the Gensini score. This is consistent with the study by Schroeder et al. [18] , who established that FMD is not useful in predicting the severity of CAD. Several studies have demonstrated that patients with Type II diabetes have marked impairment of endothelium-dependent vasodilation [19] [20] [21] . Both IGT and diabetes are often undiagnosed in patients with stable CAD [4, 5] , which was also confirmed in our present study where approx. 60 % of patients with confirmed CAD, had no previously known diabetes or IGT and normal fasting plasma levels showed abnormal glucose metabolism. Moreover, impaired arterial response to β-adrenergic stimulation (mediated via β-adrenergic receptors present on the endothelial surface) was the only clinical variable varying between subjects with abnormal glucose metabolism and patients with a normal response to OGTT. Multivariable analysis showed that the impaired vasodilator response to salbutamol was significantly associated only with abnormal glucose metabolism (IGT or diabetes) and age.
BRS in patients with stable CAD
The autonomic nervous system influences cardiovascular physiology, at least partly, by the arterial baroreflex. BRS is regarded as an index of sympathoparasympathetic balance. It was observed that alteration in BRS in patients with CAD is a useful marker of increased risk of arrhythmic events [22] . Moreover, the landmark ATRAMI study showed that depressed BRS (measured by the phenylephrine method) was an independent risk factor for all-cause mortality in the survivors of MI [3] .
Autonomic dysfunction in diabetes is associated with an increased risk of mortality. Several studies have shown that disturbances in glucose metabolism affect BRS [23] [24] [25] . In the CAD patients in the present study, BRS did not differ between those with IGT and/or diabetes and subjects with normal OGTT. We have shown by multivariable analysis that BRS was affected by age (a known phenomenon), previous MI and, interestingly, by the extent of the stenosis of coronary artery as assessed by the Gensini score. It is tempting to speculate that one of the possible explanations for the lack of difference in BRS between the study population may be the fact that all patients had normal fasting glucose levels. It seems very likely that the autonomic dysfunction observed in patients with diabetes is a function of time and the degree of metabolic disturbances, thus the lack of overt diabetes may contribute to the results obtained.
Study limitation
The OGTT was performed 48-72 h post-PTCA, therefore one cannot exclude the effect of the performed procedure on the outcome of the OGTT. However, Norhammar et al. [4] have shown that a high prevalence of abnormal glucose metabolism in patients with acute MI was still present after 3 months of follow-up, when the effect of acute stress has subsided. In their study, only 35 % of subjects had normal OGTT. It is important to note that as high as 67 % of our patients had suffered from an MI in the past, 52 % were hypertensive and 67 % smoked cigarettes. However, the introduction of these factors, as well as BP, into the multivariable analysis did not improve the percentage variance explained by the model (results not shown).
Our results are also limited by the effects of polypharmacotherapy; however, there were no significant differences in the use of ACE (angiotensin-convertingenzyme) inhibitors, statins or β-blockers in patients with a normal or impaired response to glucose load.
We have not included healthy controls in the present study, since it is generally accepted that subjects without risk factors have more compliant arteries and that their endothelium-dependent vasodilation is unimpaired. We did not test the effect of nitroglycerine-induced nonendothelium dependent vasodilation. In our experience, there is no difference between patients with diabetes/IGT and healthy controls with regard to endothelium-independent vasomotor function (results not shown). We are also not aware of studies showing abnormal endotheliumindependent vasodilation in patients with diabetes/IGT [6] .
The endothelial response to salbutamol determines AIx evaluation; since we did not measure plasma salbutamol levels one cannot exclude that difference in drug absorption may influence the results obtained to some extent. However, in their original study, Wilkinson et al. [7] showed an excellent response and repeatability to salbutamol challenge. Moreover, the concentration of salbutamol is not commonly measured or even recommended to be regularly assessed in patients undergoing endothelial function testing.
The overall number of patients is limited, with 16 showing normal OGTT, which may explain why glucose tolerance is not predictive of BRS in multivariate analysis, similarly a lack of statistical power due to small sample size may be responsible for an insignificant difference in haemodynamics and stiffness parameters between patients with diabetes/IGT and those with normal OGTT.
Conclusions
The present study reveals that patients with established CAD, normal fasting glucose concentration and IGT or diabetes (diagnosed based on OGTT), when compared with the subgroup with normal OGTT, had a reduced vasodilator response to salbutamol, which may suggest the presence of endothelial dysfunction. The degree of endothelial dysfunction did not correlate with the extent of coronary artery involvement. Conversely, BRS was not affected by glucose metabolism, but showed a significant association with the extent of coronary narrowing.
